Market Place
Sourcing Support
ResMed pegs Philips recall to add up to $350M in sales
06 Aug 2021 //
MEDTECHDIVE
Philips unveils MRI tech for total heart scans in under 1 minute
01 Jul 2021 //
FIERCEBIOTECH
Novartis Corp. v. West-Ward Pharmaceuticals Int`l (Fed. Cir. 2019)
17 May 2019 //
PATENTDOCS
New Hikma CEO Olafsson gets to work on 200 more generics layoffs
17 Mar 2018 //
FIERCE PHARMA
Roxane Lab`s Withdrawal of Approval of a NDA for ROXICODONE (Oxycodone HCl)
29 Nov 2017 //
FEDERALREGISTER
Roxane’s Generic Flucytosine Receives Approval In US
20 Oct 2017 //
FDA
Astellas Sues Roxane Over Generic Cancer Drug ANDA
12 May 2017 //
LAW360
Boehringer Whacks More Jobs in U.S.
03 Dec 2016 //
FIERCE PHARMA
USPTO Dismisses Petition for Inter Partes Review of Fanapt® Patent
31 Aug 2016 //
PR NEWSWIRE
Hikma looks at Roxane Labs plant for expanded contract work
29 Aug 2016 //
FIERCE MANUFACTURING
Vanda (VNDA) Investors Elated Over Drug Patent Ruling
26 Aug 2016 //
BIOSPACE
USFDA granted Final Approvals for Banzel ANDA`s
18 May 2016 //
TWO FOUR INSIGHT
Roxane`s Generic Rufinamide approved in US as an anticonvulsant medication
16 May 2016 //
FDA
Drugmaker exploit REMS to restrict generics, it doesn`t bode well for biosimilar
07 Mar 2016 //
FIERCE PHARMA
Boehringer, AbbVie Said to Be in Cancer-Partnership Talks
01 Mar 2016 //
BLOOMBERG
Hikma slashes $535M from offer price for Boehringer`s U.S. generics biz
11 Feb 2016 //
FIERCE PHARMA
VR315 US completes clinical study
11 Jan 2016 //
CPHI-ONLINE
Roxane`s Generic Dutasteride approved in US for Symptomatic BPH In Men
24 Nov 2015 //
FDA
Roxane`s Generic Methamphetamine HCl approved in US, hyperactivity disorder
17 Nov 2015 //
FDA
Shire victorious in US Vyvanse patent battle
25 Sep 2015 //
PHARMA TIMES
Vanda Announces Favorable Markman Ruling in Fanapt® Patent Infringement Litigation
10 Sep 2015 //
PR NEWS WIRE
In Case You Missed It ,We Did! Prometheus Takes Action Against FDA Over Generic LOTRONEX Approval...
25 Jun 2015 //
FDA LAW BLOG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.